Company Filing History:
Years Active: 2020-2022
Title: Noa Shelach: Innovator in Cancer Treatment
Introduction
Noa Shelach is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the field of cancer treatment, particularly through her innovative use of BRAF inhibitors. With a total of 6 patents, her work has the potential to improve the quality of life for patients undergoing cancer therapies.
Latest Patents
Noa Shelach's latest patents include groundbreaking technologies aimed at addressing cutaneous reactions associated with cancer treatments. One of her notable inventions is the use of BRAF inhibitors for treating cutaneous reactions caused by treatment with a MEK inhibitor. This technology relates to compositions comprising BRAF inhibitors and their applications in treating and preventing MEK inhibitor-associated cutaneous conditions. Additionally, she has developed methods for using topical BRAF inhibitor compositions to treat radiation dermatitis. This invention provides a therapeutic approach to ameliorate the effects of radiation dermatitis caused by radiotherapy.
Career Highlights
Throughout her career, Noa Shelach has worked with esteemed organizations such as Lutris Pharma Ltd. and Memorial Sloan Kettering Cancer Center. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer treatment.
Collaborations
Noa Shelach has collaborated with notable colleagues, including Noa Lowenton-Spier and Neal Rosen. These partnerships have fostered an environment of innovation and have led to the development of effective treatment methods.
Conclusion
Noa Shelach's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the medical field. Her work continues to pave the way for advancements in patient care and treatment options.